Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: A Comparison Chocolate With and Without High Cocoa Solids in Patients With Type 2 Diabetes in a Randomised Clinical Trial [NA]
A randomized clinical trial comparing chocolate with high cocoa solids to chocolate with low cocoa solids in adults with type 2 diabetes; re…
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: TReatment by Insulin Continuous Infusion in Type 2 DIAbetes [Phase 4]
Phase 4 study evaluating insulin continuous infusion for Type 2 diabetes; the current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: The Effects of a Pre-packaged, Portion Controlled Meal Plan on Type 2 Diabetes and Glycemic Control: A Comparison Study [NA]
This completed comparative clinical trial assesses whether a pre-packaged, portion-controlled meal plan improves obesity-related measures an…
-
FDA approval · 2013-06-28FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. to update lab…
-
FDA approval · 2013-06-28FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) filed by Merck Sharp & Dohme LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial comparing biphasic insulin aspart with a NPH plus regular insulin combination in type 2 diabetes has completed.
-
FDA approval · 2013-06-27FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251) [Phase 3]
A Phase 3 trial compared sitagliptin with glimepiride in elderly adults with type 2 diabetes mellitus; the study completed and results were …
-
CLINICAL_TRIALS research · 2013-06-27Clinical Trial Update: The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial update examining the effects of short-term exenatide therapy in newly diagnosed Type 2 diabetes mellitus patients, sp…
-
FDA approval · 2013-06-26FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for alogliptin submitted by Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Diabetes Treatment With Glucobay in Combination With Sulfonylurea
Bayer conducted a clinical trial evaluating Glucobay (acarbose) in combination with a sulfonylurea for type 2 diabetes. The study status is …
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione [Phase 2]
A Phase 2 trial evaluating TT223 in patients with type 2 diabetes who are taking metformin and/or thiazolidinedione; the study has completed…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Effect of Dietary Fiber on Glucose & Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM) [NA]
A completed clinical trial evaluating the effect of dietary fiber on glucose and lipid levels in individuals with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients [NA]
A clinical trial update evaluating whether a sleep education program improves glycemic control in Hong Kong Chinese patients with Type 2 Dia…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics [Phase 2]
APAD2 is a Phase 2 clinical trial evaluating a rehabilitation program in adapted physical activity for people with Type 2 diabetes mellitus.…
-
FDA approval · 2013-06-18FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2013-06-18FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Tradjenta (linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval updates the…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment [Phase 4]
Phase 4 clinical trial assessing how insulin treatment affects fat distribution in overweight and obese adults with type 2 diabetes; results…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects [Phase 2]
Phase 2 clinical trial evaluating EV-077 in type 2 diabetes assessing safety, tolerability, pharmacokinetics and pharmacodynamics; the study…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes [Phase 4]
This Phase 4 trial compared two insulin regimens (insulin detemir with insulin aspart vs NPH insulin with human soluble insulin) with or wit…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg [Phase 1]
This update reports the completion of a Phase 1 bioequivalence crossover study comparing Glucobay ODT 100 mg with Glucobay standard tablet 1…
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Vitamin D and Omega-3 Inhibit Metabolic Syndrome [Phase 3]
Phase 3 trial update suggests Vitamin D and Omega-3 may inhibit metabolic syndrome components. The results come from a completed Phase 3 stu…
-
FDA approval · 2013-06-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Eli Lilly's insulin lispro product, updating regulatory status for the approved formulation. Thi…
-
FDA label_change · 2013-06-12FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
The FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) submitted by Avvisto Therapeutics LLC. The action involves…
-
CLINICAL_TRIALS other · 2013-06-12Clinical Trial Update: the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes [Phase 4]
This is a Phase 4 clinical trial update evaluating the effect of Vitamin D (cholecalciferol) on serum thioredoxin, TBP-2, thioredoxin reduct…